Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer

Objectives. NLR (neutrophil-lymphocyte ratio) and PLR (platelet-lymphocyte ratio) are prognostic markers of differentiated thyroid cancers. In our study, we evaluated NLR, PLR and C-reactive protein (CRP) for predicting the occurence of differentiated thyroid cancer. This is the first study that com...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ozmen S, Timur O, Calik I, Altinkaynak K, Simsek E, Gozcu H, Arslan A, Carlioglu A
Formato: article
Lenguaje:EN
Publicado: Sciendo 2017
Materias:
Acceso en línea:https://doaj.org/article/b38c36bf5eda495b8056b731cd737301
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b38c36bf5eda495b8056b731cd737301
record_format dspace
spelling oai:doaj.org-article:b38c36bf5eda495b8056b731cd7373012021-12-02T16:33:01ZNeutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer1336-032910.1515/enr-2017-0013https://doaj.org/article/b38c36bf5eda495b8056b731cd7373012017-07-01T00:00:00Zhttps://doi.org/10.1515/enr-2017-0013https://doaj.org/toc/1336-0329Objectives. NLR (neutrophil-lymphocyte ratio) and PLR (platelet-lymphocyte ratio) are prognostic markers of differentiated thyroid cancers. In our study, we evaluated NLR, PLR and C-reactive protein (CRP) for predicting the occurence of differentiated thyroid cancer. This is the first study that compares NLR and PLR to C-reactive protein indifferantiated thyroid cancer not only papillary cancer but also folliculer cancer.Ozmen STimur OCalik IAltinkaynak KSimsek EGozcu HArslan ACarlioglu ASciendoarticleneutrophil-lymphocyte ratioplatelet-lymphocyte ratioc-reactive proteindifferentiated thyroid cancerDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENEndocrine Regulations, Vol 51, Iss 3, Pp 131-136 (2017)
institution DOAJ
collection DOAJ
language EN
topic neutrophil-lymphocyte ratio
platelet-lymphocyte ratio
c-reactive protein
differentiated thyroid cancer
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle neutrophil-lymphocyte ratio
platelet-lymphocyte ratio
c-reactive protein
differentiated thyroid cancer
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Ozmen S
Timur O
Calik I
Altinkaynak K
Simsek E
Gozcu H
Arslan A
Carlioglu A
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer
description Objectives. NLR (neutrophil-lymphocyte ratio) and PLR (platelet-lymphocyte ratio) are prognostic markers of differentiated thyroid cancers. In our study, we evaluated NLR, PLR and C-reactive protein (CRP) for predicting the occurence of differentiated thyroid cancer. This is the first study that compares NLR and PLR to C-reactive protein indifferantiated thyroid cancer not only papillary cancer but also folliculer cancer.
format article
author Ozmen S
Timur O
Calik I
Altinkaynak K
Simsek E
Gozcu H
Arslan A
Carlioglu A
author_facet Ozmen S
Timur O
Calik I
Altinkaynak K
Simsek E
Gozcu H
Arslan A
Carlioglu A
author_sort Ozmen S
title Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer
title_short Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer
title_full Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer
title_fullStr Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer
title_full_unstemmed Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer
title_sort neutrophil-lymphocyte ratio (nlr) and platelet-lymphocyte ratio (plr) may be superior to c-reactive protein (crp) for predicting the occurrence of differentiated thyroid cancer
publisher Sciendo
publishDate 2017
url https://doaj.org/article/b38c36bf5eda495b8056b731cd737301
work_keys_str_mv AT ozmens neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
AT timuro neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
AT caliki neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
AT altinkaynakk neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
AT simseke neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
AT gozcuh neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
AT arslana neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
AT carlioglua neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer
_version_ 1718383775494176768